Loading...
Express Scripts Holding Company
ESRX•NASDAQ
$92.33
$0.00(0.00%)

Over the last four quarters, Express Scripts Holding Company's revenue moved from $25.38B in Q4 2017 to $25.56B in Q3 2018. Operating income in Q3 2018 was $1.49B, with a strong operating margin of 6%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Express Scripts Holding Company remained robust at $2.00B, reflecting operational efficiency. Net income rose to $1.07B, with an EPS of $1.90. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan